PE000651
Jump to navigation
Jump to search
| Name | K.N[H5N4S2]GSLFAFR.G |
|---|---|
| Sequence | NGSLFAFR |
| Glycans(s) | H5N4S2 (N1) |
| Mod(s) | |
| Molecular Weight | 3133.249 |
| Norm. RT | 72.909 |
| Protein | VTN (P04004) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG003752 | 43.123 | 42.845 | 71.089 | 1,039.421 | 3 | Orbitrap | Human Serum | 5 |
| TG005055 | 48.053 | 48.067 | 74.728 | 1,039.421 | 3 | Orbitrap | Human Serum | 7 |
| TG005346 | 66.123 | 66.011 | 88.848 | 1,039.421 | 3 | Orbitrap | Human Serum | 7 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG006430 | 41.160 | 41.160 | 71.874 | 1,039.421 | 3 | Orbitrap | Human Serum | 8,014,850 |
| TG008221 | 33.578 | 33.578 | 69.947 | 1,039.421 | 3 | TripleTOF | Human Serum | 404,638 |
| TG008529 | 33.703 | 33.703 | 69.383 | 1,039.421 | 3 | TripleTOF | Human Serum | 357,189 |
| TG008825 | 33.711 | 33.711 | 67.617 | 1,039.421 | 3 | TripleTOF | Human Serum | 324,139 |
| TG009138 | 33.000 | 33.000 | 69.497 | 1,039.421 | 3 | TripleTOF | Human Serum | 282,072 |
| TG009438 | 33.650 | 33.650 | 69.744 | 1,039.421 | 3 | TripleTOF | Human Serum | 237,979 |
| TG009823 | 33.576 | 33.576 | 69.565 | 1,039.421 | 3 | TripleTOF | Human Serum | 146,785 |
| TG010272 | 33.637 | 33.637 | 70.535 | 1,039.421 | 3 | TripleTOF | Human Serum | 111,304 |
| TG010670 | 33.393 | 33.393 | 68.745 | 1,039.421 | 3 | TripleTOF | Human Serum | 56,444.4 |
| TG006506 | 31.777 | 31.777 | 72.488 | 1,039.421 | 3 | TripleTOF | Human Serum | 2,812.72 |